Cargando…
Commonly Prescribed Anticoagulants Exert Anticancer Effects in Oral Squamous Cell Carcinoma Cells In Vitro
SIMPLE SUMMARY: Oral squamous cell carcinoma (OSCC) is the sixth most common cancer worldwide with 840,000 new cases and 420,000 deaths in 2020. Anticoagulants are widely prescribed medications routinely administered to help prevent blood clots. Despite the great relevance of these two topics, there...
Autores principales: | Ling, Li-Qiao R., Lin, Zichen, Paolini, Rita, Farah, Camile S., McCullough, Michael, Lim, Mathew A. W. T., Celentano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027634/ https://www.ncbi.nlm.nih.gov/pubmed/35453795 http://dx.doi.org/10.3390/biology11040596 |
Ejemplares similares
-
Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro
por: Celentano, Antonio, et al.
Publicado: (2020) -
The Role of Glucose Transporters in Oral Squamous Cell Carcinoma
por: Botha, Heinrich, et al.
Publicado: (2021) -
Transcriptional regulation of glucose transporters in human oral squamous cell carcinoma cells
por: Paolini, Rita, et al.
Publicado: (2022) -
Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review
por: Yap, Tami, et al.
Publicado: (2020) -
Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)